Vitae

Showing 2 posts of 2 posts found.

allergan

Allergan snaps up Vitae Pharma for $639 million

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition

Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …

Novartis’ Christine Brennan joins Vitae

July 26, 2010
Sales and Marketing Vitae, appointment, sales and marketing

US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. She has over 10 years industry experience and …

The Gateway to Local Adoption Series

Latest content